These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 35572724)
1. A New Inflammation-Related Risk Model for Predicting Hepatocellular Carcinoma Prognosis. Xing M; Li J Biomed Res Int; 2022; 2022():5396128. PubMed ID: 35572724 [TBL] [Abstract][Full Text] [Related]
2. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. Long M; Zhou Z; Wei X; Lin Q; Qiu M; Zhou Y; Chen P; Jiang Y; Wen Q; Liu Y; Li R; Zhou X; Yu H Front Immunol; 2022; 13():1023349. PubMed ID: 36353638 [TBL] [Abstract][Full Text] [Related]
3. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis. Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412 [TBL] [Abstract][Full Text] [Related]
4. A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients. Ye D; Liu Y; Li G; Sun B; Peng J; Xu Q Front Oncol; 2021; 11():766072. PubMed ID: 34868990 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma. Wang Y; Song F; Zhang X; Yang C Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359 [TBL] [Abstract][Full Text] [Related]
6. Development of a Predictive Immune-Related Gene Signature Associated With Hepatocellular Carcinoma Patient Prognosis. Lei J; Zhang D; Yao C; Ding S; Lu Z Cancer Control; 2020; 27(1):1073274820977114. PubMed ID: 33269615 [TBL] [Abstract][Full Text] [Related]
7. A novel immune signature to predict the prognosis of patients with hepatocellular carcinoma. Li Q; Fan B; Ding J; Xiang X; Zhang J Medicine (Baltimore); 2021 Aug; 100(33):e26948. PubMed ID: 34414957 [TBL] [Abstract][Full Text] [Related]
8. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma. Dai K; Liu C; Guan G; Cai J; Wu L BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781 [TBL] [Abstract][Full Text] [Related]
9. A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma. Yan Q; Zheng W; Wang B; Ye B; Luo H; Yang X; Zhang P; Wang X BioData Min; 2021 May; 14(1):29. PubMed ID: 33962640 [TBL] [Abstract][Full Text] [Related]
10. An inflammation-related gene landscape predicts prognosis and response to immunotherapy in virus-associated hepatocellular carcinoma. Gao YJ; Li SR; Huang Y Front Oncol; 2023; 13():1118152. PubMed ID: 36969014 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of a robust immune-related risk signature for hepatocellular carcinoma. Liu Z; Jiao D; Liu L; Zhou X; Yao Y; Li Z; Li J; Chen J; Lei Q; Han X Medicine (Baltimore); 2021 Mar; 100(10):e24683. PubMed ID: 33725827 [TBL] [Abstract][Full Text] [Related]
12. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma. Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324 [TBL] [Abstract][Full Text] [Related]
13. A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells. Wang Y; Yang Y; Zhao Z; Sun H; Luo D; Huttad L; Zhang B; Han B BMC Cancer; 2022 Apr; 22(1):379. PubMed ID: 35397536 [TBL] [Abstract][Full Text] [Related]
14. Risk stratification and prognosis prediction based on inflammation-related gene signature in lung squamous carcinoma. Zhai W; Chen S; Duan F; Wang J; Zhao Z; Lin Y; Rao B; Wang Y; Zheng L; Long H Cancer Med; 2023 Feb; 12(4):4968-4980. PubMed ID: 36056909 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic values of pyroptosis-related genes for the hepatocellular carcinoma. Xing M; Li J BMC Bioinformatics; 2022 May; 23(1):177. PubMed ID: 35562678 [TBL] [Abstract][Full Text] [Related]
16. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma. Lin Z; Xu Q; Miao D; Yu F Front Oncol; 2021; 11():644416. PubMed ID: 33828988 [TBL] [Abstract][Full Text] [Related]
17. Identification and validation of ADME genes as prognosis and therapy markers for hepatocellular carcinoma patients. Wang J; Han K; Zhang C; Chen X; Li Y; Zhu L; Luo T Biosci Rep; 2021 May; 41(5):. PubMed ID: 33988674 [TBL] [Abstract][Full Text] [Related]
18. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177 [TBL] [Abstract][Full Text] [Related]
19. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]